Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range.
Shah, Maryam and Rattray, Zahra and Day, Katie and Uddin, Shahid and Curtis, Robin and van der walle, Christopher F. and Pluen, Alain (2017) Evaluation of aggregate and silicone-oil counts in pre-filled siliconized syringes: An orthogonal study characterising the entire subvisible size range. International Journal of Pharmaceutics, 519 (1-2). pp. 58-66. ISSN 1873-3476 (https://doi.org/10.1016/j.ijpharm.2017.01.015)
Preview |
Text.
Filename: Rattray_etal_IJP_2017_Evaluation_of_aggregate_and_silicone_oil_counts_in_pre_filled_siliconized_syringes.pdf
Accepted Author Manuscript License: Download (727kB)| Preview |
Abstract
Characterisation of particulates in therapeutic monoclonal antibody (mAb) formulations is routinely extended to the sub-visible size-range (0.1–10 μm). Additionally, with the increased use of pre-filled syringes (PFS), particle differentiation is required between proteinaceous and non-proteinaceous particles such as silicone-oil droplets. Here, three orthogonal techniques: Raster Image Correlation Spectroscopy (RICS), Resonance Mass Measurements (RMM) and Micro-Flow Imaging (MFI), were evaluated with respect to their sub-visible particle measurement and characterisation capabilities. Particle formation in mAb PFS solutions was evaluated with increasing polysorbate-20 (PS-20) concentrations. All three techniques provided complementary but distinct information on protein aggregate and silicone-oil droplet presence. PS-20 limited the generation of mAb aggregates during agitation, while increasing the number of silicone-oil droplets (PS-20 concentration dependant). MFI and RMM revealed PS-20 lead to the formation of larger micron-sized droplets, with RICS revealing an increase in smaller sub-micron droplets. Subtle differences in data sets complicate the apparent correlation between silicone-oil sloughing and mAb aggregates’ generation. RICS (though the use of a specific dye) demonstrates an improved selectivity for mAb aggregates, a broader measurement size-range and smaller sample volume requirement. Thus, RICS is proposed to add value to the currently available particle measurement techniques and enable informed decisions during mAb formulation development.
ORCID iDs
Shah, Maryam, Rattray, Zahra ORCID: https://orcid.org/0000-0002-8371-8549, Day, Katie, Uddin, Shahid, Curtis, Robin, van der walle, Christopher F. and Pluen, Alain;-
-
Item type: Article ID code: 65465 Dates: DateEvent9 January 2017Published7 January 2017Accepted13 September 2016SubmittedSubjects: Medicine > Pharmacy and materia medica Department: Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences Depositing user: Pure Administrator Date deposited: 18 Sep 2018 14:30 Last modified: 27 Sep 2024 01:09 Related URLs: URI: https://strathprints.strath.ac.uk/id/eprint/65465